A detailed history of Abeille Asset Management Sa transactions in Eli Lilly & CO stock. As of the latest transaction made, Abeille Asset Management Sa holds 150,226 shares of LLY stock, worth $120 Million. This represents 1.97% of its overall portfolio holdings.

Number of Shares
150,226
Previous 150,822 0.4%
Holding current value
$120 Million
Previous $48.8 Million 12.69%
% of portfolio
1.97%
Previous 1.89%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 20, 2023

SELL
$321.55 - $374.67 $191,643 - $223,303
-596 Reduced 0.4%
150,226 $55 Million
Q3 2022

Nov 14, 2022

BUY
$296.48 - $337.87 $10.5 Million - $12 Million
35,383 Added 30.65%
150,822 $48.8 Million
Q2 2022

Aug 04, 2022

BUY
$278.73 - $327.27 $32.2 Million - $37.8 Million
115,439 New
115,439 $37.4 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Abeille Asset Management Sa Portfolio

Follow Abeille Asset Management Sa and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Abeille Asset Management Sa, based on Form 13F filings with the SEC.

News

Stay updated on Abeille Asset Management Sa with notifications on news.